Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05163171
Other study ID # RNI 2021 VICARD-OLAGNE
Secondary ID 2021-A01356-35
Status Completed
Phase
First received
Last updated
Start date January 10, 2022
Est. completion date July 20, 2022

Study information

Verified date July 2022
Source University Hospital, Clermont-Ferrand
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Intimate partner violence and addictions are two frequent problematics with many consequences on health. A link between intimate partner violence and addictions has been found in many studies. Being a drug user increases the risk to be a perpetrator and also a victim of intimate partner violence. So, it is legitimate to question ourselves about the prevalence of the victims and perpetrators of intimate partner violence among the patients consulting or being hospitalized for an addiction problem. We believe that this prevalence will be high among these patients. On the other hand, the general practitioners are in first line receiving victims and perpetrators of violence and patients with addiction problems. So it is important to know the profiles of these patients and their expectations from their general practitioners.


Description:

The different places where the study will take place are: - 7 outpatient addiction centers: Addictology consultations in CHU Clermont-Ferrand, CH Sainte-Marie, CH Thiers, CH Ambert, ANPAA (Association Nationale de Prévention en Alcoologie et en Addictologie) of Clermont-Ferrand, Thiers and Ambert. - 3 hospital addiction centers: Addictology hospital services of CHU of Clermont-Ferrand, CH Thiers and Clémentel. This study will be based on the filling of self-answered questionnaires by the patients consulting or being hospitalized in the different recruited centers. The questionnaire will be proposed to the patient after the consultation with the practitioner. An information about the study and the anonymity will be given to the patient. The filled questionnaire will be put by the patient in a closed envelope and then in a collection box located in the waiting room. The different boxes of the different centers will be checked regularly and then the questionnaires will be analysed. The analysis of these questionnaires will allow to describe the population consulting or being hospitalized for addiction problems in the Puy-de-Dôme: age, gender, type of the addiction, the presence of intimate partner violence, associated factors of the violence, recourse characteristics to general practitioners and expectations of GP. We will evaluate the prevalence of victimization and perpetration of intimate partner violence among patients consulting or being hospitalized for addiction problems in the Puy-de-Dôme. We estimate the duration of the study at around 6 months.


Recruitment information / eligibility

Status Completed
Enrollment 122
Est. completion date July 20, 2022
Est. primary completion date July 20, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient over 18, being or having been in a relationship, consulting or being hospitalized for an addiction problem - Patient speaking and writing French - Patient capable of giving his informed consent to take part to the study - Affiliation to the social security - Patient who doesn't have a tobacco addiction only Exclusion Criteria: - refuse to participate

Study Design


Related Conditions & MeSH terms


Intervention

Other:
questionnaire
questionnaire for conjugal violence prevalence

Locations

Country Name City State
France CHU de Clermont-Ferrand Clermont-Ferrand

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Clermont-Ferrand General medicine department of Clermont-Ferrand's university

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Prevalence of the victimization Prevalence of the victimization and the perpetration of intimate partner violence in patients consulting or being hospitalized for addiction problems who had filled the questionnaire. This prevalence will be measured by the filling of the questions of the self-answered questionnaire by the patients. day 0
Secondary Prevalence of each addiction prevalence will be measured by the filling of the questions of the self-answered questionnaire by the patients. Day 0
Secondary Socio-demographic characteristics age in years Day 0
Secondary Socio-demographic characteristics male or female Day 0
Secondary Recourse at general practitioner characteristics reason and frequency of consultation with their general practitioner Day 0
Secondary Expectations by the patients of the general practitioners about addictions and intimate partner violence qualitative answer Day 0
See also
  Status Clinical Trial Phase
Terminated NCT03576768 - QuitFast: Evaluating Transcranial Magnetic Stimulation as a Tool to Reduce Smoking Directly Following a Quit Attempt N/A
Completed NCT04110626 - Realistic Evaluation of Expériences Animées, a School-based Intervention in Nouvelle Aquitaine
Completed NCT03007940 - Using NIATx Strategies to Implement Integrated Services in Routine Care N/A
Not yet recruiting NCT04030858 - The INFINITE Study: A Prospective Investigation of a Nutrient-dense Diet in Early Addiction Recovery N/A
Completed NCT03347643 - The Effectiveness of tDCS on Internet Game Addiction Phase 2
Active, not recruiting NCT02836080 - Integrated Collaborative Care Teams for Youth With Mental Health and/or Addiction Challenges (YouthCan IMPACT) N/A
Completed NCT03221985 - ESM Pilot: Mobile Phones and Psychology N/A
Completed NCT02556060 - Lamotrigine for Ketamine Dependence Trial Phase 2/Phase 3
Completed NCT02812810 - Evaluation of the Efficacy of Repetitive Transcranial Magnetic Stimulation (rTMS) Low-frequency on Craving in Smoking Dependence N/A
Completed NCT01531153 - Cognitive Enhancement as a Target for Cocaine Pharmacotherapy N/A
Recruiting NCT05976646 - Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion Phase 1/Phase 2
Completed NCT04409106 - The Turkish Version of the Parental Smartphone Use Management Scale (PSUMS)
Recruiting NCT05595759 - Violence Against Women in Patients With Alcohol Substance Addiction Training N/A
Completed NCT04099173 - A Brief Mindfulness-Based Intervention for Suicidal Ideation N/A
Recruiting NCT04959643 - Systematic Screening for Viral Hepatitis B and C at the PASS Consultation of the Montpellier University Hospital
Completed NCT04133688 - Mobile App in Addiction N/A
Recruiting NCT04063267 - Electronic Cigarettes as a Harm Reduction Strategy in Individuals With Substance Use Disorder Phase 2
Completed NCT05114577 - Recovery Sleepers: A Pilot Study of a Sleep Health Intervention for College Students in Recovery N/A
Terminated NCT02671240 - Prognosis of Behavioral Addiction in Parkinson's Disease
Not yet recruiting NCT03813095 - Exploratory Dose Ranging Study Assessing APH-1501 for the Treatment of Opioid Addiction Phase 2